Key stats
About ACE GLOBAL BIG PHARMA
Home page
Inception date
Nov 19, 2024
Replication method
Synthetic
Dividend treatment
Distributes
Primary advisor
Korea Investment Management Co., Ltd.
ISIN
KR7497510008
KIM ACE Global Big Pharma ETF is an exchange-traded fund incorporated in South Korea. The objective of the fund is to achieve return that closely replicates the performance of Solactive Global Big Pharma Index PR
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history